Symbol="XERS"
AssetType="Common Stock"
Name="Xeris Pharmaceuticals Inc"
Description="Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets ready-to-use injectable and infusible drug formulations. The company is headquartered in Chicago, Illinois."
CIK="1867096"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="180 N. LASALLE STREET, SUITE 1600, CHICAGO, IL, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="291099000"
EBITDA="-42287000"
PERatio="None"
PEGRatio="None"
BookValue="0.099"
DividendPerShare="0"
DividendYield="0"
EPS="-0.54"
RevenuePerShareTTM="0.981"
ProfitMargin="-0.533"
OperatingMarginTTM="-0.407"
ReturnOnAssetsTTM="-0.105"
ReturnOnEquityTTM="-1.631"
RevenueTTM="134073000"
GrossProfitTTM="87614000"
DilutedEPSTTM="-0.54"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.502"
AnalystTargetPrice="5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1.849"
PriceToBookRatio="3.409"
EVToRevenue="2.362"
EVToEBITDA="-2.101"
Beta="1.81"
num_52WeekHigh="3.07"
num_52WeekLow="0.97"
num_50DayMovingAverage="2.571"
num_200DayMovingAverage="1.885"
SharesOutstanding="137311000"
DividendDate="None"
ExDividendDate="None"
symbol="XERS"
open="2.12"
high="2.42"
low="2.08"
price="2.39"
volume="1746476.00"
latest_trading_day="2023-08-18"
previous_close="2.12"
change="0.27"
change_percent="12.7358%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="12"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="88"
Volume_recent_avg="1250724"
Change_recent_avg="0.01"
Delta_recent_avg="0.16"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="0.42"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="88"
Aroon_momentum_negative="12"
image_negative_thumbnail_id_1="510"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0095.jpeg"
image_negative_thumbnail_id_2="492"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0113.jpeg"
image_neutral_thumbnail_id_1="569"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_neutral_thumbnail_id_2="566"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_positive_thumbnail_id_1="663"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0045.jpeg"
image_positive_thumbnail_id_2="650"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0058.jpeg"
image_professor_thumbnail_id_1="1182"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
image_professor_thumbnail_id_2="1195"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
